21/06/2024 Healthcare
Rabeprazole Injection, branded as Ruto-IV, is a potent proton pump inhibitor used to manage severe gastroesophageal reflux disease (GERD) and gastric ulcers. Administered intravenously, it swiftly reduces stomach acid production, providing rapid relief from symptoms such as heartburn and acid regurgitation. Ruto-IV is crucial in clinical settings where oral medication is impractical or ineffective, ensuring effective control of acid-related disorders with its fast-acting formulation.Available in PCD Franchise for injectable range and third party manufacturing.
Rabeprazole Injection, branded as Ruto-IV, is a potent proton pump inhibitor used to manage severe gastroesophageal reflux disease (GERD) and gastric ...
Rabeprazole Injection IP, marketed as Satmorab-IV, is a potent intravenous medication used primarily for treating severe gastroesophageal reflux disea...
OneKrit is one of the trusted critical care injectable PCD companies in India, offering high-quality critical care products to meet hospital and emerg...
Kroyf Labcorp offers a trusted PCD Pharma Franchise for Injectable Range, empowering partners with high-quality, WHO-GMP certified injectables. Our ad...
More Details